OKOlga V. Kustova

Olga V. Kustova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olga V. Kustova has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The first experience of using magnetic resonance tomography for lung imaging in children with cystic fibrosis: opportunities and prospects

    by R. I. Mustafin, O. V. Kustova, O. I. Simonova, A. V. Anikin

    Cystic fibrosis (CF) is a hereditary disease associated with systemic failure of the exocrine glands. In 95% of the cases, progressive damage to the lung tissue occurs that requires follow-up. The main imaging methods are radiography and computed tomography (CT). Both methods involve ionizing radiation. According to clinical guidelines, a chest X-ray is performed no more than once every 2 years. However, given the high risk of developing inflammatory processes in children with CF, the frequency of radiological examinations may increase significantly. The search for alternative methods without ionizing radiation is in great demand among children with CF. One of these methods is magnetic resonance imaging (MRI).The aim was to explore the capabilities of MRI for imaging lung tissue in children with CF.Methods. The study included 12 patients aged 7 to 18 years with newly diagnosed and previously diagnosed CF. All children underwent CT and MRI of the chest.Results. In all children (100%), chest CT revealed a complex of changes typical of CF: signs of chronic bronchitis, widespread saccular and cylindrical bronchiectasis of various localizations, areas of pulmonary fibrosis, infiltrative changes in the lung tissue. Chest MRI is most effective (100%) in identifying areas of pulmonary fibrosis (thickening of the lung tissue), accumulation of exudate in the lumen of bronchiectasis, and infiltrative changes. In contrast to CT, MRI is less effective in the assessment of bronchitis changes with thickening of the bronchial walls without exudate (83%). A low efficiency of MRI is observed in the visualization of bronchiectasis with a free lumen (without signs of mucostasis).Conclusion. Radiography and computed tomography remain the main methods for lung imaging in children with CF. However, taking into account the absence of ionizing radiation, the development of the method and the emergence of new sequences, chest MRI can be used effectively for follow-up instead of radiography and CT, reducing the radiation dose received.

  • Open Access

    Primary ciliary dyskinesia (Kartagener syndrome): a case of late diagnosis and follow-up

    by O. I. Simonova, L. R Selimzianova, A. Yu Simonova, Yu. V. Gorinova, O. V. Kustova, A. V. Lazareva, M. M. Platonova, E. A. Vishneva, Yu. A. Bosenko

    Primary ciliary dyskinesia (PCD) is an autosomal recessive disease that develops as a result of an ultrastructural defect of the cilia and flagella. The symptoms are non-specific, especially in childhood, and are characterized by recurrent rhinitis and bronchitis, often with obstruction. Half of the patients with PCD are diagnosed with such clear clinical manifestation as Kartagener’s syndrome (chronic bronchitis, chronic sinusitis, reverse position of internal organs (situs inversus), but even in these cases the diagnosis can be difficult.The aim of this paper was to demonstrate a clinical case of late diagnosis of PCD in a child with classic Kartagener syndrome and concomitant atopy, and the results of 11 years of follow-up and microbiological monitoring. The stages of the diagnostic search are presented in detail and typical errors on the way to diagnosis are analyzed.Conclusion. This clinical observation demonstrates the difficulties of diagnosing PCD in a patient with concomitant atopy. It is noted that appropriate continued monitoring and timely therapy are crucial for children with PCD. The need to standardize approaches to the diagnosis and management of patients with PCD, including continuity during transfer to the adult healthcare network, is emphasized.


  • Open Access

    Single-breath diffusion capacity of the lungs for carbon monoxide in children with cystic fibrosis: methods of interpreting results

    by S. G. Bystrova, O. I. Simonova, E. E. Akhmedova, O. V. Kustova

    Introduction. Progression of pulmonary and heart failure often causes death in patients with cystic fibrosis (95%). Therefore, monitoring of lung condition is very important for patients with cystic fibrosis (CF). Structural changes are visualized by computed tomography of the chest (CT) and are scored using the Brody scale. For children older than 5 years, pulmonary function tests (PFTs) tests (which are evaluated in percent of predicted (%) values) are available, such as spirometry, body plethysmography (BP), diffusion capacity of the lungs (DL) test. The results of the single-breath (SB) DL for carbon monoxide test are DLCO-SB, alveolar volume (VA-SB) and their ratio (KCO-SB). In the presence of non-communicative zones for gas perfusion, VA-SB may not present true VA. For patients with CF, it is proposed to use VA determined by BP for calculating KCO-BP, or to adjust the predicted DLCO-SB and KCO-SB for VA.Aim. To assess the informativeness DLCO-SB, KCO-SB and KCO-BP in children with CF.Materials and methods. 28 children with CF (8–18 years old) were examined in the department of pulmonology of the National Research Center for Children’s Health. PFTs included DLCO-SB, spirometry and BP. Additionally, we evaluated the data of the blood gas and acid-base values, age, body mass index and CT scores.Results and discussion. We found that in most patients DLCO-SB and KCO-SB were within the normal range, and decreased in children older than 14 years with background of severe bronchiectasis.Conclusion. Thus, in children with CF the DL test is informative, and adjustment for VA is useful.

  • Open Access

    Changes in external respiration in patients with cystic fibrosis with various infectious pathogens and structural damage to the lungs

    by Serafima G. Bystrova, Olga I. Simonova, Olga V. Kustova, Elina E. Akhmedova, Anna V. Lazareva

    The progression of lung failure in children with cystic fibrosis (CF) is associated with chronic lung infection (Staphylococcus aureus, Pseudomonas aeruginosa, Achromobacter spp., etc.). Functional pulmonary tests (PFTs), spirometry and body plethysmography, computed tomography (CT) of the lungs and analysis of the lung microbiota are used for monitoring of lung condition of CF patients. Several studies have been devoted to assessing the correlation of structural changes in CT and pulmonary function tests (PFT), but at the moment there is not enough data on the relationship of these indicators and their differences depending on the respiratory microbiota in CF children in the Russian population. Materials and methods. Data was collected for CF 8–17.9 years children patients. We retrospectively analyzed genotype, body mass index, results of PFTs and CT scan of the chest (score by the Brody scale), deep throat cultures in all patients, and the capillary blood gas — in 56 children. Results. Significant correlations between functional tests and structural changes in the lungs were found. A trend towards impairment of PFTs and CT scores with age due to infectious pathogens was shown, and the most significant negative impact was exerted by the mucoid species Pseudomonas aeruginosa and, especially, Achromobacter spp. The last one was associated with the worst lung parameters in CF children. Conclusion. Pirometry, body plethysmography, and CT of the lungs are necessary for a comprehensive assessment of the lung condition, and a study of the lung microbiome due to its influence on structural and function changes in patients with CF.

  • COMPUTED TOMOGRAPHY SEMIOTICS OF NEUROENDOCRINE CELLULAR HYPERPLASIA IN INFANTS: CLINICAL AND RADIOLOGICAL COMPARISONS

    by M.A. Karpenko, S.V. Epifanova, D.Yu. Ovsyannikov, Moscow Morozov Children’s City Clinical Hospital, Sh.A. Gitinov, P.A. Frolov, O.V. Kustova, E.V. Schepkina, S.V. Zaytseva, S.V. Starevskaya

    The neuroendocrine cell hyperplasia of infancy (NEHI) is an interstitial lung disease (ILD) of an unknown etiology that manifests itself in children of the first year of life and is characterized by the presence of persistent tachypnea of infancy (PTI) syndrome and nonspecific changes in lung biopsy in the form of hyperplasia of bombesin-positive neuroendocrine cells of the peripheral respiratory tract diagnosed in typical cases based on computed tomography (CT) of the lungs. The purpose of the study was to characterize the CT picture of NEHI in comparison with the severity of the disease. Materials and methods of the study: a multicenter observational cross-sectional study that was maintained January, 2012 March, 2022 portraying 83 patients with NEHI using the NEHI clinical diagnostic scale, ILD severity scale, pulse oximetry, chest CT and echocardiography. Results: CT-semiotics of NEHI is characterized by ground-glass opacification in 97% of cases with predominant localization in the middle lobe of the right lung (89%), upper lobe of the right lung (74%), in the upper lobe of the left lung (72%) and lingual segments (68%) with a prevalence in most cases not exceeding 25% of the total area of the lung fields on sections in the axial projection; parenchymal changes in the form of linear and reticular shading (4%), consolidation (15%), a symptom of “mosaic pneumatization” (35%); and thickening of the walls of the bronchi (28%). Based on the sum of scores on the clinical scale for diagnosing of NEHI, it is impossible to predict the prevalence of CT changes (Rs=0.12, p=0.5), whilst the severity of NEHI does not statistically significantly depend on the ground glass opacification area (Rs=0 .27, p=0.13). Conclusion: The most common CT-identified symptoms of NEHI are the symptoms of ground glass and “mosaic pneumatization” as well as the thickening of the bronchial walls.


  • Open Access

    Neuroendocrine hyperplasia of infancy: 10-year observational study

    by Olga I. Simonova, Anastasiya A. Krasyukova, Dmitry Yu. Ovsyannikov, Galina I. Smirnova, Vitaly V. Meshcheryakov, Olga V. Kustova, Anna R. Babayan, Maksim V. Simonov

    The aim of the study is to establish the prevalence of neuroendocrine hyperplasia of infancy (NEHI) in the structure of chronic lung diseases (CLD) and congenital lung malformations (CLM), clinical and instrumental diagnostics of these diseases in patients hospitalized at the National Medical Research Center for Children’s Health, Moscow over the period from 2012 to 2022. Materials and methods. Longitudinal non comparative single-center study of fourteen NEHI patients, diagnosed on the basis of 3 out of 4 signs of childhood CHILD-syndrome and the presence of typical CT signs of diseases, CLD and CLM patients. In all NEHI patients, the prevalence of clinical and instrumental signs was determined according to the scale, which includes 10 signs: onset of signs before the age of 12 months, delayed physical development, absence of drumstick symptom, absence of cough and wheezing (apart from episodes of respiratory infections), chest abnormalities, crackles, hypoxemia, tachypnea, retraction. Results. NEHI is a rare (0.53%) CLD in infants. The clinical scale for the diagnosis of NEHI is of practical importance in the early diagnosis of diseases; its use can reduce the prescription of drugs that are not effective for NEHI.

  • CLINICAL DIAGNOSIS SCALE FOR NEUROENDOCRINE CELL HYPERPLASIA IN INFANTS: INFORMATIVENESS AND DIFFERENTIAL DIAGNOSTIC SIGNIFICANCE

    by M.A. Karpenko, D.Yu. Ovsyannikov, Moscow Morozov Children’s City Clinical Hospital, M.A. Zhestkova, P.A. Frolov, I.K. Asherova, Yaroslavl Yaroslavl City Central Hospital, Sh.A. Gitinov, O.I. Zhdanova, M. Daniel-Abu, et al.

    Neuroendocrine cell hyperplasia of infancy (NEHI) is an interstitial lung disease of unknown etiology that develops in the first year of life and manifests itself as persistent tachypnea syndrome. The aim of the study was to determine the diagnostic value of the clinical scale for the diagnosis of NEHI in comparison with computed tomography (CT) data of the chest organs and for differential diagnosis with acute bronchiolitis (AB)/community-acquired pneumonia (CAP). Materials and methods of research: a multicenter case-control study of children aged 21 days of life to 12 months was carried out: – 83 children with NEHI and 83 infants with AB or CAP. To determine the sensitivity and specificity of this scale for differential diagnosis with AB/CAP, the results of the assessment according to the proposed scale were compared in patients with NEHI (study group) and patients with AB/CAP (control group) on the day of treatment and after 3 weeks. Results: the sensitivity of the clinical scale for the diagnosis of NEHI when compared with the CT data of the chest organs was 85.5%. In the differential diagnosis of NEHI with AB/CAP on the day of treatment, the sensitivity of the clinical scale for the diagnosis of NEHI was 85.5%, the specificity was 80.7%; when re-evaluated after 3 weeks, the accuracy of the scale increased from 83.1% to 91.6%, the specificity – from 80.7% to 97.6%. Diagnosis on a scale after 3 weeks reduced the possibility of overdiagnosis of NEHI from 19.3% to 2.4%. Conclusions: the clinical scale for the diagnosis of NEHI has a high diagnostic value in comparison with the results of CT scan of the chest organs and for differential diagnosis with AB/CAP, especially when re-evaluating.


  • Open Access

    Features of the visualization of the liver in children with glycogen storage disease according to data of computed tomography

    by Andrey N. Surkov, L. S. Namazova-Baranova, O. V. Kustova, A. S. Potapov, A. V. Anikin, A. N. Getman, V. I. Barskiy, G. V. Volynets, I. E. Smirnov

    Diagnostic value of computed tomography (CT) of the liver imaging in children with glycogen storage disease (GSD) is still poorly understood, in this connection, there were examined 59 patients with essential hypertension (study group) and 27 - with Wilson's disease (WD) (control group). In dependence on the type of GSD patients of the main group were divided into 3 groups: 1st with GSD Type I (n = 18), 2nd - with GSD type III (n = 21), the third - with the GSD type VI/IX (n = 20). Reference group was consisted of 107 children without liver disease. CT of the abdominal cavity on multislice computed tomography Light Speed 16 and 750 HD (GE, USA) was performed in all cases. The pronounced hepatomegaly with predominant increase in the left lobe and the index of I segment was established to be the common diagnostic CT sign, typical for all types of GSD. The change in the X-ray density of the liver parenchyma, dependent on the type of disease is also the feature of the CT-picture of liver parenchyma. In GD type I there was often noted the decline in the X-ray density of the liver parenchyma, while in GSD types III and VI there was identified a significant increase in the density of the organ tissue, which was related with morphological changes in the liver parenchyma, caused by the deposition of glycogen in hepatocytes, fat and protein dystrophy. The authors believe that CT of the abdominal cavity can be an alternative, non-invasive, relatively inexpensive and accessible way to diagnose GD, which is especially important in pediatric practice.